Sonoma制药 SNOA 深 沪
等待开盘 05-12 09:30:00 美东时间
1.15
-0.030
-2.54%
华盛通- 最 高1.23
- 今 开1.19
- 成交量 5.47万股
- 最 低 1.12
- 昨 收 1.18
- 总市值 356.24万
- 52周最高 6.9199
- 市盈率 静 --
- 换手率 1.77%
- 52周最低 0.8501
- 委 比 97.73%
- 总股本 309.77万
- 历史最高 74.232
- 量 比 0.95
- 振 幅 9.32%
- 历史最低 0.06
- 每 手 1
- 风险率 0.79%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Dow Falls Over 150 Points; Procter & Gamble Posts Upbeat Earnings
U.S. stocks traded mixed midway through trading, with the Dow Jones index falli...
04-25 00:51
Sono Shines at Transport Logistic 2025: Showcasing Solar-Integrated Transport Solutions
Sono Group showcased its solar integration solutions for commercial vehicles at Transport Logistic 2025, attracting strong interest and generating significant business leads, marking another milestone in its mission to revolutionize the industry.
2025-06-09 10:00
Market-Moving News for March 11th
LFMD: 33% | LifeMD shares are trading higher after the company reported better-than-expected Q4 financial results and issued Q1 and FY25 revenue guidance above estimates. KSS: -18% | Kohl's shares are
2025-03-11 19:19
Why Paymentus Holdings Shares Are Trading Higher By Over 8%; Here Are 20 Stocks Moving Premarket
Shares of Paymentus Holdings, Inc. (NYSE:PAY) rose sharply in today's pre-marke...
2025-03-11 18:55
阿尔凯默斯盘中异动 股价大涨5.01%
北京时间2024年10月12日02时35分，阿尔凯默斯（ALKS.us）股票出现波动，股价急速拉升5.01%。截至发稿，该股报28.74美元/股，成交量79.2642万股，换手率0.48%，振幅5.26%。 最近的财报数据显示，该股实现营业收入3.99亿美元，净利润94.66百万美元，每股收益0.54美元，毛利3.36亿美元，市盈率16.79倍。 机构评级方面，在所有14家参与评级的机构中，57%的券商给予买入建议，36%的券商给予持有建议，7%的券商给予卖出建议。 阿尔凯默斯股票所在的制药行业中，整体涨幅为1.30%。其相关个股中，Cyclo Therapeutics Inc C/Wts 1...
2024-10-12 02:35
Sonoma Pharmaceuticals, Inc.盘中异动 下午盘急速上涨7.34%
北京时间2024年10月11日01时40分，Sonoma Pharmaceuticals, Inc.（SNOA.us）股票出现异动，股价大幅上涨7.34%。截至发稿，该股报3.07美元/股，成交量9.4787万股，换手率7.08%，振幅8.37%。 最近的财报数据显示，该股实现营业收入3.39百万美元，净利润-1.14百万美元，每股收益-1.34美元，毛利1.31百万美元，市盈率-0.50倍。 机构评级方面，在所有1家参与评级的机构中，100%的券商给予买入建议，无券商给予持有、卖出建议。 Sonoma Pharmaceuticals, Inc.股票所在的制药行业中，整体跌幅为0.36%。其相...
2024-10-11 01:40
Sonoma Pharmaceuticals And EMC Pharma Announce Collaboration To Co-market An Expanded Eye Care Product Line, Will Also Feature Refreshed Design And Improved Packaging For Ocucyn Eyelid & Eyelash Cleanser
Sonoma Pharmaceuticals, Inc. (NASDAQ:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications,
2024-09-11 20:36
Why Sonoma Pharmaceuticals (SNOA) Stock Is Moving
Sonoma Pharmaceuticals Inc (NASDAQ:SNOA) shares are trading lower by 11.9% to $0.19 Wednesday morning after the company announced a 1-for-20 reverse stock split. The stock will trade on a split-adjusted basis starting August 30, 2024. This move aims to meet Nasdaq’s $1.00 minimum bid price requireme...
2024-08-28 21:32
Sonoma Pharmaceuticals to Effect 1-for-20 Reverse Stock Split
07:21 AM EDT, 08/28/2024 (MT Newswires) -- Sonoma Pharmaceuticals (SNOA) said Wednesday it will effect a 1-for-20 reverse split of its common shares this Thursday. Trading on an adjusted basis will begin Friday on the Nasdaq Capital Market, the company said. The reverse stock split is intended to in...
2024-08-28 19:21
Sonoma Pharmaceuticals Signs Agreement With Medline Industries to Market, Distribute Wound Care Products in US
09:28 AM EDT, 08/21/2024 (MT Newswires) -- Sonoma Pharmaceuticals (SNOA) said in a regulatory filing Wednesday it signed a five-year agreement with Medline Industries to market and distribute Sonoma's wound care products in the US. Financial terms of the agreement were not disclosed. The agreement i...
2024-08-21 21:28
